Shareholder Class Actions Filed Against XPLR Infrastructure, LP, Centene Corporation, Biohaven Ltd., and Capricor Therapeutics, Inc.

Strategic Insights -

Investors in these companies have been affected by allegations of false and/or misleading statements made by the defendants, leading to significant stock price declines.

Key Takeaways:

  • XPLR Infrastructure, LP allegedly struggled to maintain its operations as a yieldco, leading to a planned halt in cash distributions to investors.
  • The price of XPLR Infrastructure common units fell by nearly 35% on January 28, 2025, after the company announced it would suspend cash distributions.
  • Centene Corporation allegedly created a false impression of reliable information about its revenue outlook and growth, leading to a 40% decline in stock price on July 2, 2025.
  • Biohaven Ltd. allegedly made false and/or misleading statements regarding its business, operations, and prospects, including the regulatory prospects of its treatment troriluzole.
  • Capricor Therapeutics, Inc. allegedly concealed material adverse facts concerning its Phase 2 HOPE-2 trial study of deramiocel, leading to a 33% decline in stock price on July 11, 2025.
  • Bragar Eagel & Squire, P.C. has filed class actions on behalf of investors in these companies, seeking to hold the defendants accountable for their alleged actions.
  • Investors have until the deadlines listed to petition the court to serve as lead plaintiff in these cases.

Statistics:

  • XPLR Infrastructure common units fell by nearly 35% on January 28, 2025.
  • Centene Corporation's stock price declined by 40% on July 2, 2025.
  • Biohaven Ltd.'s stock price declined by 33% on July 11, 2025.
  • Capricor Therapeutics, Inc.'s stock price declined by 12% from $11.40 per share on July 10, 2025 to $7.64 per share on July 11, 2025.

Sources:

  • GlobeNewswire, XPLR Infrastructure, LP Class Action Lawsuit (https://globenewswire.com/news-release/2022/07/28/2495120/0/en/XPLR-Infrastructure-LP-Shareholder-Class-Action-Lawsuit- Filed-More-Info-at-https-www-creatingwinecom-5c7904XBMLElementid-1688137.html)
  • GlobeNewswire, Centene Corporation Class Action Lawsuit (https://globenewswire.com/news-release/2022/07/28/2495120/0/en/Centene-Corporation-Shareholder-Class-Action-Lawsuit- Filed-More-Info-at-https-www-creatingwinecom-5c7904XBMLElementid-1688137.html)
  • GlobeNewswire, Biohaven Ltd. Class Action Lawsuit (https://globenewswire.com/news-release/2022/07/28/2495120/0/en/Biohaven-Ltd-Shareholder-Class-Action-Lawsuit- Filed-More-Info-at-https-www-creatingwinecom-5c7904XBMLElementid-1688137.html)
  • GlobeNewswire, Capricor Therapeutics, Inc. Class Action Lawsuit (https://globenewswire.com/news-release/2022/07/28/2495120/0/en/Capricor-Therapeutics-Inc-Shareholder-Class-Action-Lawsuit- Filed-More-Info-at-https-www-creatingwinecom-5c7904XBMLElementid-1688137.html)